A Brexit transition period to 31 December 2020 is good news for the Life Sciences industry.   Brexit negotiators have now agreed Article 122 - that EU laws will apply until the end of this transition period.  This means that the EU Medical Devices Regulation (but not the In Vitro Diagnostics Regulstion) will fully apply in the UK before Brexit.